Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2017

Sep 7, 2017

30786_dirs_2017-09-06_4bac6cac-030c-4806-9a35-83f12d804277.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-09-05

Reporting Person: STARK JAMES R (VP, Corporate Controller)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-09-05 Restricted Stock Units $0 A 1500 Acquired Bio-Rad A Common Stock (1500) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 0 Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F2: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.